PMID

Data

Article Title

Organization

Gemfibrozil derivatives as activators of soluble guanylyl cyclase - A structure-activity study.

Baylor University

Soluble guanylate cyclase stimulators for the treatment of hypertension: Discovery of MK-2947.

Merck

Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF).

The Institute of Cancer Research

Design and synthesis of oxime ethers of alpha-acyl-beta-phenylpropanoic acids as PPAR dual agonists.

Lg Life Sciences

1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.

Nerviano Medical Sciences

1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.

Bristol-Myers Squibb Pharmaceutical Research Institute